Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk.

International journal of cancer

Liu D, Zhu J, Zhou D, Nikas EG, Mitanis NT, Sun Y, Wu C, Mancuso N, Cox NJ, Wang L, Freedland SJ, Haiman CA, Gamazon ER, Nikas JB, Wu L.
PMID: 34520569
Int J Cancer. 2022 Jan 01;150(1):80-90. doi: 10.1002/ijc.33808. Epub 2021 Sep 25.

A large proportion of heritability for prostate cancer risk remains unknown. Transcriptome-wide association study combined with validation comparing overall levels will help to identify candidate genes potentially playing a role in prostate cancer development. Using data from the Genotype-Tissue...

Cite
Liu D, Zhu J, Zhou D, et al. A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk. Int J Cancer. 2021;150(1):80-90doi: 10.1002/ijc.33808.
Liu, D., Zhu, J., Zhou, D., Nikas, E. G., Mitanis, N. T., Sun, Y., Wu, C., Mancuso, N., Cox, N. J., Wang, L., Freedland, S. J., Haiman, C. A., Gamazon, E. R., Nikas, J. B., & Wu, L. (2022). A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk. International journal of cancer, 150(1), 80-90. https://doi.org/10.1002/ijc.33808
Liu, Duo, et al. "A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk." International journal of cancer vol. 150,1 (2022): 80-90. doi: https://doi.org/10.1002/ijc.33808
Liu D, Zhu J, Zhou D, Nikas EG, Mitanis NT, Sun Y, Wu C, Mancuso N, Cox NJ, Wang L, Freedland SJ, Haiman CA, Gamazon ER, Nikas JB, Wu L. A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk. Int J Cancer. 2022 Jan 01;150(1):80-90. doi: 10.1002/ijc.33808. Epub 2021 Sep 25. PMID: 34520569; PMCID: PMC8595764.
Copy Download .nbib Format: NLM
Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Toth R, Scherer D, Kelemen LE, Risch A, Hazra A, Balavarca Y, Issa JJ, Moreno V, Eeles RA, Ogino S, Wu X, Ye Y, Hung RJ, Goode EL, Ulrich CM.
PMID: 28115406
Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):816-825. doi: 10.1158/1055-9965.EPI-16-0728. Epub 2017 Jan 23.

No abstract available.

Cite
Toth R, Scherer D, Kelemen LE, et al. Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. Cancer Epidemiol Biomarkers Prev. 2017;26(6):816-825doi: 10.1158/1055-9965.EPI-16-0728.
Toth, R., Scherer, D., Kelemen, L. E., Risch, A., Hazra, A., Balavarca, Y., Issa, J. J., Moreno, V., Eeles, R. A., Ogino, S., Wu, X., Ye, Y., Hung, R. J., Goode, E. L., Ulrich, C. M. (2017). Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 26(6), 816-825. https://doi.org/10.1158/1055-9965.EPI-16-0728
Toth, Reka, et al. "Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 26,6 (2017): 816-825. doi: https://doi.org/10.1158/1055-9965.EPI-16-0728
Toth R, Scherer D, Kelemen LE, Risch A, Hazra A, Balavarca Y, Issa JJ, Moreno V, Eeles RA, Ogino S, Wu X, Ye Y, Hung RJ, Goode EL, Ulrich CM. Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):816-825. doi: 10.1158/1055-9965.EPI-16-0728. Epub 2017 Jan 23. PMID: 28115406; PMCID: PMC6054308.
Copy Download .nbib Format: NLM
Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer.

Cancer communications (London, England)

Wu C, Zhu J, King A, Tong X, Lu Q, Park JY, Wang L, Gao G, Deng HW, Yang Y, Knudsen KE, Rebbeck TR, Long J, Zheng W, Pan W, Conti DV, Haiman CA, Wu L.
PMID: 34520132
Cancer Commun (Lond). 2021 Dec;41(12):1387-1397. doi: 10.1002/cac2.12205. Epub 2021 Sep 14.

BACKGROUND: DNA methylation and gene expression are known to play important roles in the etiology of human diseases such as prostate cancer (PCa). However, it has not yet been possible to incorporate information of DNA methylation and gene expression...

Cite
Wu C, Zhu J, King A, et al. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer. Cancer Commun (Lond). 2021;41(12):1387-1397doi: 10.1002/cac2.12205.
Wu, C., Zhu, J., King, A., Tong, X., Lu, Q., Park, J. Y., Wang, L., Gao, G., Deng, H. W., Yang, Y., Knudsen, K. E., Rebbeck, T. R., Long, J., Zheng, W., Pan, W., Conti, D. V., Haiman, C. A., & Wu, L. (2021). Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer. Cancer communications (London, England), 41(12), 1387-1397. https://doi.org/10.1002/cac2.12205
Wu, Chong, et al. "Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer." Cancer communications (London, England) vol. 41,12 (2021): 1387-1397. doi: https://doi.org/10.1002/cac2.12205
Wu C, Zhu J, King A, Tong X, Lu Q, Park JY, Wang L, Gao G, Deng HW, Yang Y, Knudsen KE, Rebbeck TR, Long J, Zheng W, Pan W, Conti DV, Haiman CA, Wu L. Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer. Cancer Commun (Lond). 2021 Dec;41(12):1387-1397. doi: 10.1002/cac2.12205. Epub 2021 Sep 14. PMID: 34520132; PMCID: PMC8696216.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries